The particulars: Tianjin · Finland. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably comfortable…
All questions
Newest first. 5.2k questions across 107 tags.
The particulars: potassium · ecnoglutide. I am at the decision point and I would rather think it through than improvise. I would rather spend money on measurement…
The particulars: liraglutide · 10 mg/mL. I would like the arithmetic checked rather than the conclusion asserted. I have deliberately not used an online calculator…
For reference: 4 °C · ecnoglutide. I would like to know whether this claim survives contact with evidence. If the answer is "nobody has tested that", I would like…
The specifics, since they change the answer: fibrillation · 2–8 °C. I understand the observation; what I do not understand is the mechanism behind it. I have read the…
The particulars: LDL-C · mazdutide. I am trying to build something sustainable rather than something thorough that I will abandon. I have already decided the broad…
What I am working with: 2.4 mg · eight weeks · early satiety. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody knows,…
Eight weeks in on tirzepatide and I cannot work out which of two things is happening, and I think it matters. Version A: my appetite drive is genuinely reduced, food…
Details up front: creatinine · mazdutide. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody knows, I would rather hear…
The specifics, since they change the answer: Medutest · Xi’an Mokemei Biotechnology. I have read the primary source rather than the summary, which has left me with…
Setup, so nobody has to ask: Suzhou · Sweden. I have read the primary source rather than the summary, which has left me with more questions. I understand the…
For reference: JEEP · Shanghai · Japan. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum viable…
Details up front: 68 kg · 1,200 kcal. This should be a straightforward calculation and I keep getting two different answers. The numbers are arbitrary; the method is…
This is my second independent submission on material from the same supplier. This is a planning question. I know what my options are; I do not know how to weigh them.…
Numbers first: PIONEER-4 · nausea · 25 mg. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
This is my second independent submission on material from the same supplier. I can parse the result. I am less sure what it licenses me to conclude. I have…
What I have: a GLP-1 receptor agonist · five days. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know…
The particulars: KP · orforglipron. I have a result I cannot explain, and I would rather diagnose it than guess. I have checked the obvious explanations and…
For reference: QST · oral semaglutide. I have two candidate explanations and no way to distinguish them. The same procedure has worked without incident several times…
I am comparing a supplier certificate against an independent result on the same lot. I would like to know the limits of what can be inferred from this. What I am…
The specifics, since they change the answer: Guangzhou · Germany. I would like to know the limits of what can be inferred from this. What I am trying to avoid is…
Concretely: 99.4% · date of analysis. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result,…
Stated plainly: chromatogram · QYB. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would like the plan…
Conditions: a 25G drawing needle · tirzepatide · 10 mg/mL. I would like the axes of comparison first and the recommendation second. I have tried the first option and…